Literature DB >> 9807705

Cytokine and matrix metalloproteinase expression in pigmented villonodular synovitis may mediate bone and cartilage destruction.

R J O'Keefe1, R N Rosier, L A Teot, J M Stewart, D G Hicks.   

Abstract

BACKGROUND: Pigmented villonodular synovitis (PVNS) is characterized by hypervascular proliferative synovium containing multinucleated giant cells, macrophages, and hemosiderin. The destruction of articular cartilage and erosion of periarticular bone is thought to be mediated by matrix metalloproteinases (MMPs). Expression of MMPs in some tumors appears to be stimulated through local production of cytokines, and several specific cytokines (TNF alpha, IL-1, and IL-6) play an important role in the stimulation of osteoclastic bone resorption. The role of cytokine secretion and regulation of MMP production in PVNS has not been investigated.
DESIGN: In the present study, ten specimens from eight patients (ages 19 to 80) were evaluated histologically according to a modified Mirra classification and immunohistochemically (IHC) for the expression of MMP-9 (92 kDa gelatinase B), tumor necrosis factor alpha (TNF alpha), interleukin 1-beta (IL-1 beta), and interleukin 6 (IL-6). Localization of IL-6 and TNF alpha production was confirmed by in situ hybridization (ISH) for mRNA.
RESULTS: All specimens, regardless of location (six knees, one ankle, one subtalar joint), showed diffuse and intense immunoreactivity for cytokines in the giant cells and synovial cells, and less intense and diffuse staining in the activated macrophages. Staining in the fibroblastic elements was minimal. In situ hybridization for TNF alpha and IL-6 mRNA mirrored the immunohistochemistry results, although the IL-6 staining was weaker than that for TNF alpha. Immunoreactivity for MMP-9 was diffuse and strong in giant cells, diffuse and moderate in synovial cells, and focal and moderate to strong in macrophages. In contrast, normal synovium demonstrated focal, moderate immunoreactivity for IL-1 beta, IL-6, TNF alpha and MMP-9 localized in the synovial lining cells.
CONCLUSION: These findings suggest that periarticular bone resorption and cartilage destruction which characterize PVNS may be related to the expression of inflammatory cytokines, which in turn stimulate MMP production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9807705      PMCID: PMC2378164     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  15 in total

1.  The pathology of the joint tissues and its clinical relevance in prosthesis failure.

Authors:  J M Mirra; H C Amstutz; M Matos; R Gold
Journal:  Clin Orthop Relat Res       Date:  1976-06       Impact factor: 4.176

2.  Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.

Authors:  R J O'Keefe; L A Teot; D Singh; J E Puzas; R N Rosier; D G Hicks
Journal:  Lab Invest       Date:  1997-04       Impact factor: 5.662

3.  Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption.

Authors:  S M Horowitz; S B Doty; J M Lane; A H Burstein
Journal:  J Bone Joint Surg Am       Date:  1993-06       Impact factor: 5.284

4.  Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading.

Authors:  E A Pickvance; T R Oegema; R C Thompson
Journal:  J Orthop Res       Date:  1993-05       Impact factor: 3.494

5.  Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Applications to musculoskeletal tissues.

Authors:  I D Crabb; S S Hughes; D G Hicks; J E Puzas; G J Tsao; R N Rosier
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

6.  Expression of metalloproteinases in pigmented villonodular synovitis.

Authors:  J M Darling; L H Glimcher; S Shortkroff; B Albano; E M Gravallese
Journal:  Hum Pathol       Date:  1994-08       Impact factor: 3.466

7.  Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta.

Authors:  Z P Lum; B E Hakala; J S Mort; A D Recklies
Journal:  J Cell Physiol       Date:  1996-02       Impact factor: 6.384

8.  In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.

Authors:  H M Lorenz; C Antoni; T Valerius; R Repp; M Grünke; N Schwerdtner; H Nüsslein; J Woody; J R Kalden; B Manger
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

9.  Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause.

Authors:  F P Cantatore; G Loverro; A M Ingrosso; R Lacanna; E Sassanelli; L Selvaggi; M Carrozzo
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

10.  Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

View more
  11 in total

1.  Pigmented Villonodular Synovitis: Dorsum Foot.

Authors:  P Kinra; B K Varghese
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Localized pigmented villonodular synovitis of the knee: acute onset in pregnancy.

Authors:  Murad Uslu; Ozgur Cetik; Pinar Atasoy; Fatih Eksioglu; Murat Engin
Journal:  Rheumatol Int       Date:  2006-05-18       Impact factor: 2.631

3.  Arthroscopic synovectomy in pigmented villonodular synovitis of the knee: clinical series and outcome.

Authors:  Jitesh K Jain; J V S Vidyasagar; Radha Sagar; Hiren Patel; Matad Lokeshwaraiah Chetan; Ashish Bajaj
Journal:  Int Orthop       Date:  2013-07-17       Impact factor: 3.075

4.  Intraarticular adalimumab in a patient with pigmented villonodular synovitis.

Authors:  Senol Kobak
Journal:  Rheumatol Int       Date:  2009-10-10       Impact factor: 2.631

Review 5.  Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies.

Authors:  Yousef Abu-Amer; Isra Darwech; John C Clohisy
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 6.  Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.

Authors:  Mehdi Brahmi; Armelle Vinceneux; Philippe A Cassier
Journal:  Curr Treat Options Oncol       Date:  2016-02

Review 7.  Periprosthetic bone loss: diagnostic and therapeutic approaches.

Authors:  Loredana Cavalli; Maria Luisa Brandi
Journal:  F1000Res       Date:  2014-06-17

8.  Expression of colony-stimulating factor 1 is associated with occurrence of osteochondral change in pigmented villonodular synovitis.

Authors:  Takehiro Ota; Hiroshi Urakawa; Eiji Kozawa; Kunihiro Ikuta; Shunsuke Hamada; Satoshi Tsukushi; Yoshie Shimoyama; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Tumour Biol       Date:  2015-02-18

9.  Synoviocytes from pigmented villonodular synovitis are less sensitive to cadmium-induced cell death than synoviocytes from rheumatoid arthritis.

Authors:  Héléna Farese; Mélissa Noack; Pierre Miossec
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.996

10.  Cadherin-11 cooperates with inflammatory factors to promote the migration and invasion of fibroblast-like synoviocytes in pigmented villonodular synovitis.

Authors:  Chenxi Cao; Fei Wu; Xingyue Niu; Xiaoqing Hu; Jin Cheng; Yan Zhang; Chuanyun Li; Xiaoning Duan; Xin Fu; Jiying Zhang; Xin Zhang; Yingfang Ao
Journal:  Theranostics       Date:  2020-08-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.